BIS(4-TERT-BUTYLPHENYL)IODONIUM HEXAFLUOROPHOSPHATE, 98%, 1g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-((diphenyl(p-tolyl)methyl)amino)pentanoic acid, 95+%, 250mg

p-Xylene, min. 99%, for synthesis, 100 ml, glass packaging

N-[1,1'-Biphenyl]-4-yl-1-naphthalenamine, 97%, 1g

(R)-N4-(Benzyloxy)-N1-((S)-1-((S)-2-((benzyloxy)methyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylsuccinamide, 97%, 25mg

(8-FLUOROQUINOLIN-3-YL)METHANOL, 95.0%, 250mg

INOSITOL NICOTINATE, 95%, 100g

1-Ethynyl-4-hexylbenzene>95.0%(GC)25g

Oxetan-2-ylmethanol, 95.0%, 100g

3-Bromo-5-fluoro-N-methylaniline, 97%, 100mg

2-Ethoxy-2-methylpropanoic acid, 95.0%, 1g

tert-Butyl 4-(2-bromopyridin-4-yl)piperazine-1-carboxylate, 95.0%, 1g

(R)-2,3-BIS(DODECANOYLOXY)PROPYL (2-(TRIMETHYLAMMONIO)ETHYL) PHOSPHATE, 97%, 100mg